Abstract
BackgroundAdoptive cellular therapies with chimeric antigen receptor T cells have revolutionized the treatment of some malignancies but have shown limited efficacy in solid tumors such as glioblastoma and face a...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have